Addex Therapeutics Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	-	3.34	3.87	6.96	20.48
Cash & Short-Term Investments	2.19	3.34	3.87	6.96	20.48
Cash Growth	-34.55%	-13.55%	-44.44%	-66.04%	9.57%
Receivables	-	0.02	0.15	0.6	0.32
Prepaid Expenses	-	0.17	0.22	0.27	1.12
Other Current Assets	-	0.01	0	0	0.02
Total Current Assets	-	3.54	4.23	7.83	21.94
Property, Plant & Equipment	-	0.04	0.35	0.4	0.54
Long-Term Investments	-	7.09	-	-	-
Other Long-Term Assets	-	0.01	0.05	0.05	0.06
Total Assets	-	10.68	4.64	8.28	22.54
Accounts Payable	-	0.25	0.98	1.28	1.79
Accrued Expenses	-	0.54	1.4	1.72	2.06
Current Portion of Leases	-	0.01	0.27	0.29	0.29
Current Unearned Revenue	-	-	0.23	-	-
Total Current Liabilities	-	0.8	2.89	3.28	4.13
Long-Term Leases	-	0.03	0.07	0.09	0.19
Long-Term Unearned Revenue	-	-	0.09	-	-
Pension & Post-Retirement Benefits	-	0.16	0.44	-	1.28
Total Liabilities	-	1	3.5	3.37	5.61
Common Stock	-	1.84	1.84	1.15	49.27
Additional Paid-In Capital	-	266.38	266.19	269.51	283.98
Retained Earnings	-	-353.36	-360.42	-349.86	-329.06
Treasury Stock	-	-0.87	-0.91	-6.28	-11.7
Comprehensive Income & Other	-	95.68	94.44	90.39	24.44
Shareholders' Equity	5.96	9.68	1.15	4.91	16.93
Total Liabilities & Equity	-	10.68	4.64	8.28	22.54
Total Debt	0.04	0.04	0.34	0.37	0.48
Net Cash (Debt)	2.15	3.3	3.52	6.58	20
Net Cash Growth	-34.82%	-6.29%	-46.52%	-67.08%	10.34%
Net Cash Per Share	0.02	0.03	0.05	0.15	0.59
Filing Date Shares Outstanding	136.99	98.34	128.26	80.88	37.9
Total Common Shares Outstanding	116.57	98.34	125.2	77.13	37.9
Working Capital	-	2.74	1.34	4.55	17.81
Book Value Per Share	0.05	0.10	0.01	0.06	0.45
Tangible Book Value	5.96	9.68	1.15	4.91	16.93
Tangible Book Value Per Share	0.05	0.10	0.01	0.06	0.45
Machinery	-	0.08	1.73	1.72	1.72